HIGHLIGHTS
- who: Paul Grocki et al. from the Department of Chemistry and Chemical Biology, Indiana University-Purdue University, Indianapolis have published the Article: Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time, in the Journal: Molecules 2022, 4277 of /2022/
- what: This study showed that pitavastatin administered at high doses (8 mg/kg body weight) resulted in significant antitumor effects. The authors report that their expression is enriched when mice receive pitavastatin treatment at high concentrations, which is indicative of the treatment efficacy. A previous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.